Yearly Archives: 2010

INOMAX DS drug-delivery systems in the United States are being voluntarily recalled due to the potential failure of a pressure switch which may have an impact on the administration of INOMAX.

A study has found that obese adolescents with type 2 diabetes have diminished cognitive performance and subtle abnormalities in the brain as detected by Magnetic Resonance Imaging (MRI).

To minimize that pain and inconvenience, researchers at MIT's Spectroscopy Laboratory have developed a noninvasive way to measure blood glucose levels using light.

Postmenopausal women with diabetes taking thiazolidinediones (TZDS), including rosiglitazone and pioglitazone, may be at increased risk for fractures according to a new study.

Defects in insulin function - which occur in diabetes and obesity - could directly contribute to psychiatric disorders like schizophrenia.

Millions of Americans in the early stages of chronic kidney disease (CKD) are at an increased risk of having atrial fibrillation (AF).

Cashew seed extract shows promise as an effective anti-diabetic, according to a new study.

The alarming increase of morbidly obese diabetics is causing more new cases of a debilitating foot deformity called Charcot foot.

In high-risk adults with type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans.

Bioengineers have developed an implantable glucose sensor and wireless telemetry system that continuously monitors tissue glucose and transmits the information to an external receiver.

GlaxoSmithKline (GSK), the manufacturer of the diabetes drug Avandia (rosiglitazone), has been informed by FDA that the postmarketing trial known as TIDE (Thiazolidinedione Intervention With Vitamin D Evaluation) has been placed on partial clinical hold.

A new study published by JAMA shows that among patients age 65 years and older, rosiglitazone is associated with an increased risk of stroke, heart failure, and all-cause mortality when compared with pioglitazone.

In people with longstanding type 2 diabetes who are at high risk for heart attack and stroke, lowering blood sugar to near-normal levels did not delay the combined risk of diabetic damage to kidneys, eyes, or nerves, but did delay several other signs of diabetic damage.

In high-risk adults with type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans.

In a step toward curing diabetes, scientists at Washington University School of Medicine in St. Louis have alleviated the disease using transplants from both embryonic and adult pigs.

Report suggests that aggressively pursuing low blood pressure and cholesterol levels may not benefit, and could even harm, some patients with diabetes.